Thrombin Activates AMP-Activated Protein Kinase in Endothelial Cells via a Pathway Involving Ca²⁺/Calmodulin-Dependent Protein Kinase Kinase β

REFERENCES

• Aley, P. K., K. E. Porter, J. P. Boyle, P. J. Kemp, and C. Peers. 2005. Hypoxic modulation of Ca2+ signaling in human venous endothelial cells. Multiple roles for reactive oxygen species. J. Biol. Chem. 280:13349–13354.
   PubMedGoogle Scholar
• Reference deleted.
   Google Scholar
• Bogatcheva, N. V., J. G. Garcia, and A. D. Verin. 2002. Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Moscow) 67:75–84.
   PubMedGoogle Scholar
• Borbiev, T., A. D. Verin, S. Shi, F. Liu, and J. G. Garcia. 2001. Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L983–L990.
   PubMedGoogle Scholar
• Cacicedo, J. M., N. Yagihashi, J. F. Keaney, Jr., N. B. Ruderman, and Y. Ido. 2004. AMPK inhibits fatty acid-induced increases in NF-κB transactivation in cultured human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 324:1204–1209.
   PubMed Web of Science ®Google Scholar
• Carling, D. 2004. The AMP-activated protein kinase cascade—a unifying system for energy control. Trends Biochem. Sci. 29:18–24.
   PubMed Web of Science ®Google Scholar
• Chen, H., M. Montagnani, T. Funahashi, I. Shimomura, and M. J. Quon. 2003. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 278:45021–45026.
   PubMed Web of Science ®Google Scholar
• Chen, Z.-P., K. I. Mitchelhill, B. J. Michell, D. Stapleton, I. Rodriguez-Crespo, L. A. Witters, D. A. Power, P. R. Ortiz de Montellano, and B. E. Kemp. 1999. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 443:285–289.
   PubMed Web of Science ®Google Scholar
• Coughlin, S. R. 2005. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3:1800–1814.
   PubMed Web of Science ®Google Scholar
• Dagher, Z., N. Ruderman, K. Tornheim, and Y. Ido. 1999. The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 265:112–115.
   PubMed Web of Science ®Google Scholar
• Davies, S. P., D. Carling, and D. G. Hardie. 1989. Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur. J. Biochem. 186:123–128.
   PubMedGoogle Scholar
• Fleming, I., and R. Busse. 2003. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:R1–R12.
   PubMed Web of Science ®Google Scholar
• Fleming, I., B. Fisslthaler, S. Dimmeler, B. E. Kemp, and R. Busse. 2001. Phosphorylation of Thr495 regulates Ca2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ. Res. 88:E68–E75.
   PubMed Web of Science ®Google Scholar
• Fryer, L. G., A. Parbu-Patel, and D. Carling. 2002. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277:25226–25232.
   PubMed Web of Science ®Google Scholar
• Hamilton, J. R., J. D. Moffatt, A. G. Frauman, and T. M. Cocks. 2001. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries. J. Cardiovasc. Pharmacol. 38:108–119.
   PubMedGoogle Scholar
• Hardie, D. G. 2004. AMP-activated protein kinase: a master switch in glucose and lipid metabolism. Rev. Endocr. Metab. Disord. 5:119–125.
   PubMed Web of Science ®Google Scholar
• Hardie, D. G., and D. A. Pan. 2002. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 30:1064–1070.
   PubMed Web of Science ®Google Scholar
• Hardie, D. G., I. P. Salt, S. A. Hawley, and S. P. Davies. 1999. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338:717–722.
   PubMed Web of Science ®Google Scholar
• Hawley, S. A., J. Boudeau, J. L. Reid, K. J. Mustard, L. Udd, T. P. Mäkelä, D. R. Alessi, and D. G. Hardie. 2003. Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2:28.
   PubMedGoogle Scholar
• Hawley, S. A., D. A. Pan, K. J. Mustard, L. Ross, J. Bain, A. M. Edelman, B. G. Frenguelli, and D. G. Hardie. 2005. Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2:9–19.
   PubMed Web of Science ®Google Scholar
• Hawley, S. A., M. A. Selbert, E. G. Goldstein, A. M. Edelman, D. Carling, and D. G. Hardie. 1995. 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem. 270:27186–27191.
   PubMed Web of Science ®Google Scholar
• Heller, R., A. Unbehaun, B. Schellenberg, B. Mayer, G. Werner-Felmayer, and E. R. Werner. 2001. l-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 276:40–47.
   PubMed Web of Science ®Google Scholar
• Hong, S.-P., F. C. Leiper, A. Woods, D. Carling, and M. Carlson. 2003. Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. USA 100:8839–8843.
   PubMed Web of Science ®Google Scholar
• Hunt, R. A., G. J. Bhat, and K. M. Baker. 1999. Angiotensin II-stimulated induction of sis-inducing factor is mediated by pertussis toxin-insensitive Gq proteins in cardiac myocytes. Hypertension 34:603–608.
   PubMedGoogle Scholar
• Hurley, R. L., K. A. Anderson, J. M. Franzone, B. E. Kemp, A. R. Means, and L. A. Witters. 2005. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280:29060–29066.
   PubMed Web of Science ®Google Scholar
• Ido, Y., D. Carling, and N. Ruderman. 2002. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells. Inhibition by the AMP-activated protein kinase activation. Diabetes 51:159–167.
   PubMed Web of Science ®Google Scholar
• Johnson, J. A., M. O. Gray, J. S. Karliner, C.-H. Chen, and D. Mochly-Rosen. 1996. An improved permeabilization protocol for the introduction of peptides into cardiac myocytes. Application to protein kinase C research. Circ. Res. 79:1086–1099.
   PubMedGoogle Scholar
• Kahn, B. B., T. Alquier, D. Carling, and D. G. Hardie. 2005. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1:15–25.
   PubMed Web of Science ®Google Scholar
• Kishi, K., T. Yuasa, A. Minami, M. Yamada, A. Hagi, H. Hayashi, B. E. Kemp, L. A. Witters, and Y. Ebina. 2000. AMP-activated protein kinase is activated by the stimulations of Gq-coupled receptors. Biochem. Biophys. Res. Commun. 276:16–22.
   PubMed Web of Science ®Google Scholar
• Minami, T., A. Sugiyama, S.-Q. Wu, R. Abid, T. Kodama, and W. C. Aird. 2004. Thrombin and phenotypic modulation of the endothelium. Arterioscler. Thromb. Vasc. Biol. 24:41–53.
   PubMed Web of Science ®Google Scholar
• Morrow, V. A., F. Foufelle, J. M. Connell, J. R. Petrie, G. W. Gould, and I. P. Salt. 2003. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J. Biol. Chem. 278:31629–31639.
   PubMed Web of Science ®Google Scholar
• Mount, P. F., R. E. Hill, S. A. Fraser, V. Levidiotis, F. Katsis, B. E. Kemp, and D. A. Power. 2005. Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177. Am. J. Physiol. Renal Physiol. 289:F1103–F1115.
   PubMedGoogle Scholar
• Nagata, D., M. Mogi, and K. Walsh. 2003. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J. Biol. Chem. 278:31000–31006.
   PubMed Web of Science ®Google Scholar
• O'Brien, P. J., N. Prevost, M. Molino, M. K. Hollinger, M. J. Woolkalis, D. S. Woulfe, and L. F. Brass. 2000. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J. Biol. Chem. 275:13502–13509.
   PubMed Web of Science ®Google Scholar
• Ouchi, N., H. Kobayashi, S. Kihara, M. Kumada, K. Sato, T. Inoue, T. Funahashi, and K. Walsh. 2004. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279:1304–1309.
   PubMed Web of Science ®Google Scholar
• Ouchi, N., R. Shibata, and K. Walsh. 2005. AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ. Res. 96:838–846.
   PubMed Web of Science ®Google Scholar
• Schulz, E., E. Anter, M.-H. Zou, and J. F. Keaney, Jr. 2005. Estradiol-mediated endothelial nitric oxide synthase association with heat shock protein 90 requires adenosine monophosphate-dependent protein kinase. Circulation 111:3473–3480.
   PubMedGoogle Scholar
• Shaw, R. J., M. Kosmatka, N. Bardeesy, R. L. Hurley, L. A. Witters, R. A. DePinho, and L. C. Cantley. 2004. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 101:3329–3335.
   PubMed Web of Science ®Google Scholar
• Reference deleted.
   Google Scholar
• Thors, B., H. Halldórsson, and G. Thorgeirsson. 2004. Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt. FEBS Lett. 573:175–180.
   PubMed Web of Science ®Google Scholar
• Tokumitsu, H., H. Inuzuka, Y. Ishikawa, M. Ikeda, I. Saji, and R. Kobayashi. 2002. STO-609, a specific inhibitor of the Ca2+/calmodulin-dependent protein kinase kinase. J. Biol. Chem. 277:15813–15818.
   PubMed Web of Science ®Google Scholar
• Tsopanoglou, N. E., and M. E. Maragoudakis. 2004. Role of thrombin in angiogenesis and tumor progression. Semin. Thromb. Hemost. 30:63–69.
   PubMed Web of Science ®Google Scholar
• Vaidyula, V. R., and A. K. Rao. 2003. Role of Gαq and phospholipase C-β2 in human platelets activation by thrombin receptors PAR1 and PAR4: studies in human platelets deficient in Gαq and phospholipase C-β2. Br. J. Haematol. 121:491–496.
   PubMedGoogle Scholar
• Woods, A., P. C. Cheung, F. C. Smith, M. D. Davison, J. Scott, R. K. Beri, and D. Carling. 1996. Characterization of AMP-activated protein kinase β and γ subunits. Assembly of the heterotrimeric complex in vitro. J. Biol. Chem. 271:10282–10290.
   PubMed Web of Science ®Google Scholar
• Woods, A., K. Dickerson, R. Heath, S.-P. Hong, M. Momcilovic, S. R. Johnstone, M. Carlson, and D. Carling. 2005. Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2:21–33.
   PubMed Web of Science ®Google Scholar
• Woods, A., S. R. Johnstone, K. Dickerson, F. C. Leiper, L. G. Fryer, D. Neumann, U. Schlattner, T. Wallimann, M. Carlson, and D. Carling. 2003. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13:2004–2008.
   PubMed Web of Science ®Google Scholar
• Woods, A., I. Salt, J. Scott, D. G. Hardie, and D. Carling. 1996. The α1 and α2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett. 397:347–351.
   PubMed Web of Science ®Google Scholar
• Zhou, G., R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M. F. Hirshman, L. J. Goodyear, and D. E. Moller. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Investig. 108:1167–1174.
   PubMed Web of Science ®Google Scholar
• Zou, M.-H., X.-Y. Hou, C.-M. Shi, S. Kirkpatick, F. Liu, M. H. Goldman, and R. A. Cohen. 2003. Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. J. Biol. Chem. 278:34003–34010.
   PubMed Web of Science ®Google Scholar
• Zou, M.-H., X.-Y. Hou, C.-M. Shi, D. Nagata, K. Walsh, and R. A. Cohen. 2002. Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J. Biol. Chem. 277:32552–32557.
   PubMed Web of Science ®Google Scholar
• Zou, M.-H., S. S. Kirkpatrick, B. J. Davis, J. S. Nelson, W. G. Wiles, IV, U. Schlattner, D. Neumann, M. Brownlee, M. B. Freeman, and M. H. Goldman. 2004. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J. Biol. Chem. 279:43940–43951.
   PubMed Web of Science ®Google Scholar